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Abstract
Background: The lp28-1 plasmid is required for persistent infection by the Lyme disease spirochete, Borrelia
burgdorferi. Mutational studies on this plasmid have shown that the vls locus is important for antigenic variation
of the VlsE lipoprotein that leads to immune evasion and persistence. However, it is still unknown whether the vls
system is the only genetic locus on this plasmid necessary for long-term infection, and thus the potential role of
non-vls genes on lp28-1 in virulence and persistence is yet to be fully determined. Despite extensive mutational
analyses, two lp28-1 regions containing the ORFs bbf19 - bbf22 and bbf27 – bbf30 have not yet been mutated in
their entirety.
Results: In this study, we set out to establish if these unstudied regions of lp28-1 play a role in spirochete
persistence. Results show that the generated mutants were fully infectious in immunocompetent mice, and were
able to persist for 91 days following infection. Following this finding, ospC expression by these mutants was
determined, as it has been reported that spirochetes lacking lp28-1 fail to downregulate expression of this
lipoprotein leading to immune clearance. Data presented here failed to show a definitive difference in ospC
expression levels during host infection when the mutants were compared to the wild type.
Conclusions: Overall, the results strongly suggest that non-vls genes residing on lp28-1 do not play a role in
spirochete persistence during infection of the mammalian host, and that the regions under study are likely not
involved in the regulation of ospC expression. In conjunction with previous studies involving mutation of non-vls
loci on lp28-1, these findings suggest that the vls locus is likely the sole genetic element on this plasmid
responsible for immune evasion and persistence exhibited by the Lyme disease pathogen.
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Background
Lyme disease is caused by infection with the tick-
transmitted spirochete, Borrelia burgdorferi. It is currently
the most common vector-borne disease in the northern
hemisphere, occurring in parts of North America, Europe
and Asia [1]. Persistent host infection by B. burgdorferi
has been linked to the presence of the 28 kilobase linear
plasmid, lp28-1, which harbors 32 open reading frames
that are designated bbf01 to bbf32 ([2, 3]; Fig. 1). Clones
lacking lp28-1 exhibit an intermediate infectivity
phenotype, whereby these spirochetes are able to dissem-
inate to tissue sites but are unable to persist in the murine
host [4–6]. Notably, these same clones are capable of
long-term survival in severe-combined immunodeficient
(SCID) mice that lack an effective antibody response
[4, 7]. Studies involving telomere-mediated deletion of
a 10 kb region (bbf31-bbf32) containing the VMP-like
sequence (vls) locus responsible for antigenic variation
of a vls-expressed (VlsE) lipoprotein found that these
mutant spirochetes are cleared in immunocompetent
mice by day 21 post infection, matching the phenotype
observed with the complete loss of lp28-1 [8, 9].
Although numerous studies have been conducted on
the importance of the vls locus, it has not been fully de-
termined whether other genes on lp28-1 play a role in
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infectivity and persistence. Mutation or deletion of the
bbf01 gene that encodes for the arthritis related protein,
Arp, was shown to exhibit a reduced ability to cause
joint inflammation, but did not alter infectivity or per-
sistence in immunocompetent mice [10, 11]. Clones
containing a deletion of bbf01 to bbf18 were found to be
fully infectious and persistent following infection in im-
munocompetent mice [8]. However, signature-tagged
transposon mutagenesis of lp28-1 [12] identified several
genes within the bbf1-18 region (bbf03, bbf05, bbf10, and
bbf18) as having a possible impact on infectivity. Region
bbf23-bbf26 of lp28-1 codes for the paralogous family
proteins 49, 32, 50 and 57, respectively. These genes are
known to be required for autonomous replication of the
lp28-1 plasmid [13], and have been shown to be required
for infectivity [12]. In addition to previous mutational
studies, work by Embers et al. found that regulation of
outer surface protein C (OspC) is impaired in spiro-
chetes lacking lp28-1, which could also potentially con-
tribute to the lack of persistence exhibited by this strain
[14]. This disregulation resulted in continued expression
of OspC, which has been shown to lead to spirochete
clearance by an adaptive host immune response [15–18].
To date, with the exception of bbf29 [19], two regions
containing the ORFs bbf19 - bbf22 and bbf27 – bbf30
have not been mutated in their entirety. Hence, the
question addressed in this study is whether loss of the
genes within these two regions has an effect on infectiv-
ity and persistence by B. burgdorferi. The bbf19-22 re-
gion encodes one pseudogene (bbf19), a conserved
hypothetical protein (bbf20), a short gene (bbf21) and a
putative p23 protein (bbf23). Region bbf27-30 encodes
mostly short genes (bbf27-29) and one pseudogene
(bbf30) [20]. To further investigate the role of non-vls
genes of lp28-1 in disease persistence and potentially the
regulation of ospC expression, mutants were generated
that lacked either region bbf1-18, bbf19-22 or bbf27-30,
and their respective impact on infectivity and disease
persistence was assessed in immunocompetent C3H
mice. Results provided here show no significant differ-
ence in infectivity and persistence between wild type B.
burgdorferi and the generated mutants. In addition, the
particular lp28-1 regions under study may not be
involved in OspC downregulation as a mechanism of
immune avoidance, as there was no significant difference
in ospC expression levels during host infection between
the wild-type and mutant clones.
Methods
B. burgdorferi clones and culture methods
Borrelia burgdorferi B31-A3 (wild type) was a kind gift
from Patti Rosa [21]. Clones described in this study were
generated from the above-mentioned B31 clone (Table 1).
All B. burgdorferi clones were cultivated in liquid BSK-II
medium supplemented with 6 % rabbit serum (Cedar-
lane Laboratories, Burlington, NC) and incubated at 35 °C
under 2.5 % CO2. Mutant strains were grown in media
supplemented with kanamycin (200 μg/ml). Cell densities
and growth phase were monitored by dark-field micros-
copy and enumerated using a Petroff-Hausser counting
chamber. Blood and tissue samples were cultured in BSK-
II supplemented with 6 % rabbit serum and containing
Borrelia antibiotic cocktail (0.02 mg/ml phosphomycin,
0.05 mg/ml rifampicin and 2.5 μg/ml amphotericin B).
Generation of lp28-1 mutant clones
The mutant lacking regions bbf1-18 was regenerated
through targeted deletion as described in a previous
publication [8]. For deletion of bbf19-22 and bbf27-30
from lp28-1 by allelic exchange, a 500 bp sequence up-
stream and downstream of each region to be deleted
was PCR amplified from the annotated lp28-1 se-
quence (NCBI Reference Sequence: NC_001851.2
http://www.ncbi.nlm.nih.gov/) using primers listed in
Table 2. The resulting DNA product was then cloned
Fig. 1 Schematic of the open reading frames of the B. burgdorferi lp28-1 plasmid. Genes are flanked by telomeres (striped regions). Double-headed
solid arrows show regions that have been previously deleted: a [11], b and c [8]. Genetic loci bbf19-22 or bbf27-30 were chosen for mutational analysis,
as there is no knowledge for their respective roles in B. burgdorferi persistence. Conserved regions (black); pseudogenes (white); short genes less than
300 bp (vertical lines); autonomous replication genes (grey)
Table 1 B. burgdorferi clones used in this study
B. burgdorferi B31 clone Missing plasmids Reference
A3 wild type cp9 [21]
A3Δbbf 1–18 (BbΔ1-18) cp9 [8]
A3Δbbf 19–22 (BbΔ19-22) cp9 This study
A3Δbbf 27–30 (BbΔ19-22) cp9 This study
5A8 (BbΔlp28-1) lp28-1 [6]
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into the pJET 2.1 plasmid vector (Fermentas, USA).
Primers annealing within the 500 bp region were then
used to amplify the DNA vector excluding the regions
to be deleted. An insert containing the aphI gene con-
ferring resistance to kanamycin driven by the flgB pro-
moter of B. burgdorferi was then ligated to this PCR
product to create the plasmid DNA construct for al-
lelic exchange (pPH17 or pPH30 for the deletion of
bbf27-30 and bbf19-22, respectively). The resulting
plasmid was then transformed into Escherichia coli
DH5α competent cells. Plasmid DNA isolated from in-
dividual E. coli clones was verified for correct size and
orientation by restriction digest before transformation
into B. burgdorferi cells.
B. burgdorferi transformation
B. burgdorferi B31-A3 wild-type cells were electropo-
rated and cultured as previously described [8, 22].
DNA from culture-positive wells was extracted using
a DNeasy Blood and Tissue Kit (Qiagen, Germantown,
MD), and used for PCR analysis to confirm the
presence of the antibiotic-resistance gene and the
absence of bbf1-18, bbf19-22 or bbf27-30 utilizing
primer sets described in Table 2. Plasmid content for
each verified transformant was determined by PCR
using plasmid-specific primers as previously de-
scribed [6].
Southern Blot analysis
Total plasmid DNA was extracted from B. burgdorferi
clones using the Plasmid Midi Kit (Qiagen) and sepa-
rated on a 1 % agarose gel at 80 V for 23 h (250 ng of
DNA was used per lane). DNA was then transferred
onto a nylon membrane and hybridized with Digoxi-
genin (DIG)-labeled probes following manufacturer’s
guidelines (Roche, Indianapolis, IN).
Infection of mice
Three to four week-old male C3H/HeN mice (Harlan,
Indianapolis, IN) were infected by subcutaneous needle
inoculation with 105 total spirochetes per dose. B. burg-
dorferi clones from frozen glycerol stock were passaged
no more than two times in vitro prior to use in mouse
infection assays. Infection was monitored by culturing
either blood samples or ear biopsies at the indicated
times post infection. After infection, mice were moni-
tored for presence of infection at day seven by blood col-
lection. Tissues for RT-qPCR analysis were collected at
days 14, 21, 56 and 91. Two ear punch biopsies of about
2 mm diameter were collected from each mouse and
Table 2 Primers used in this study
P330 GTCTGTGGTAGTTACTAGTTACTTTAAATACC Forward primer for bbf27-30 target
P331 CCGAAATATTCCTATCTACTTAACAAC Reverse primer for bbf27-30 target
P332 CCGGCCGGCGAATTTTGAGTCCTCTAGTGAGTTGTG Left primer for inverse PCR of bbf27-30 target in pJET with NgoMIV site
P333 CCGGCTAGCGTTATAAGCCCTCCATTTGATAATTTTTTG Right primer for inverse PCR of bbf27-30 target in pJET with NheI site
P366 CTTAATTTGTGACCGCCATTAGAGC Forward primer for bbf27-30 screen
P367 GGGTTTTTTGAAACAAATCTTGC Reverse primer for bbf27-30 screen
P411 GAGTTTCTGGTAAGATTAATGCTC Forward primer for flaB RT-qPCR
P412 CATTTAAATTCCCTTCTGTTGTCTGA Reverse primer for flaB RT-qPCR
P413 AGAGGTTTGTCACAAGCTTCTAGAAATACTTCAAAGGC flaB RT-qPCR probe
P482 GAACAAGCTGAAAAATATAAAAAAGTAATG Forward primer for PCR amplification of bbf19-22 target
P483 CTGGTTACTTTTTAGATAGAGTTTTTATAGAG Reverse primer for PCR amplification of bbf19-22 target
P484 CCGGCCGGCGGTTTAGACTTGCATTTA TATCTCC Left primer for inverse PCR bbf19-22 target in pJET with NgoMIV site
P485 CCGGCTAGCCCCCTCCTTATATTTTTTTATATATAAAAG Right primer for inverse PCR of bbf19-22 target in pJET with NheI site
P486 GCTTATAAGCTTTATTAACACCCATATATTC Forward primer for bbf19-22 screen
P487 CCCGCGAGGTATATTTATTTATATTG Reverse primer for bbf19-22 screen
P709 TTACGGATTCTAATGCGGTTT Forward primer for ospC RT-qPCR
P710 TTTACCAATAGCTTTAGCAGCAA Reverse primer for ospC RT-qPCR
P711 TGTGAAAGAGGTTGAAGCGTTGCTG. ospC RT-qPCR probe
P828 CTGCACTACCACAAGAGATTGCA Forward primer for PCR screen for left-end sequence of lp28-1
P829 CTCTTCTCCTCTCTTCTTCTCTCT Reverse primer for PCR screen for left-end sequence of lp28-1
P830 CATTTCTAGTCTAGATTGCAGTTATTTCTAAAATTAACT Forward primer for PCR amplification for lp28-1 left-end deletion target
P831 GTGCCCAGGCGGCCGTCCTTATTCTTCTGGCATAGAAGT Reverse primer for PCR amplification for lp28-1 left-end deletion target
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stored in RNA later in −20 °C until RNA extraction was
done.
RNA extraction and gene expression analysis by droplet
digital PCR
RNA was extracted from the tissues using the RNeasy®
Fibrous Tissue Mini Kit (Qiagen, Valencia, CA) and
treated with the RNase-free DNase set (Qiagen) to re-
move any residual DNA. The concentration, purity and
integrity of RNA were determined electrophoretically
and by measuring the absorbance. The reverse transcrip-
tion reaction was performed in a total volume of 20 μL
using iScript Advanced cDNA Synthesis Kit for RT-
qPCR (Biorad) following manufacturers guidelines. A
quantity of 100 ng total RNA was used as template. Fol-
lowing generation of cDNA, droplet digital PCR was
performed using the QX100 Droplet Digital PCR
(ddPCR™) system (Bio-Rad). The ospC and flaB genes
were amplified using primers and probes shown in
Table 2. The primer probe mixture, cDNA and 1x
ddPCR supermix were pipetted into the DG8™ Cart-
ridge for droplet formation in the QX100 droplet gener-
ator. Droplets were then transferred into a 96 well PCR
plate and heat-sealed with a foil plate seal (Biorad)
before placement into the C1000 Touch Thermal Cycler.
Reactions were performed in biological replicates in a total
volume of 40 μl. Cycling parameters (with ramping speed
at 2 °C s−1) were as follows: enzyme activation was done
at 95 °C for 10 min followed by a denaturation for 30 s at
94 °C; annealing and extension for 1 min at 60 °C was
repeated for 40 cycles. After PCR, the plate was placed in
the QX100 droplet reader and relative gene expression
determined using the QuantaSoft software.
Statistical analysis
SigmaPlot 11.0 software was used for all statistical data
analysis. Normalized ospC transcript values from mice
infected with the mutant clones were compared to tran-
script levels from mice infected with the wild type clone
on respective days tested. Results were analyzed by the
Student’s t-test and p values ≤0.05 were considered sta-
tistically significant.
Results
Generation of lp28-1 mutant B. burgdorferi clones
Genetic loci of the lp28-1 plasmid containing the genes
bbf19-22 and bbf27-30 (see Fig. 1) were chosen for mu-
tational analysis to assess their respective roles in B.
burgdorferi persistence. Deletion of each genetic region
was achieved using allelic exchange as shown in Fig. 2a.
Deletion constructs (pPH17 and pPH30) were generated
that carried a kanamycin-resistance gene (kan) driven by
Fig. 2 Generation and verification of lp28-1 mutant clones of B. burgdorferi. a Schematic of the construction strategy for the lp28-1 mutant clones
BbΔ19-22 and BbΔ27-30 by allelic exchange is shown. BbΔ1-18 was generated by targeted telomere deletion as previously described in a published
study [8]. To confirm the loss of regions bbf19-22 or bbf27-30, DNA was isolated and subjected to Southern blot analysis (b). All mutant clones
provided a positive signal of the expected size (~28 kb) when probed for the kan cassette. The blot also confirmed the absence of the targeted
region in the two mutant clones. WT, wild type; M, DNA size marker
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a B. burgdorferi flgB promoter flanked by 500 bp hom-
ologous sequences upstream and downstream of the tar-
geted region. Genetic deletion of the bbf19-22 and
bbf27-30 regions was achieved by insertion of the select-
able kan marker by homologous recombination to gen-
erate the mutant clones, BbΔ19-22 and BbΔ27-30,
respectively. Transformants were PCR screened for the
presence of the kanamycin-resistance cassette, and
clones meeting this criterion were then further analyzed
for their total plasmid profile. All clones contained the
full plasmid profile, with the exception of cp9. The cp9
plasmid is normally absent from the parental B31-A3
clone, and is not necessary for infection or pathogenesis
[21]. To confirm the loss of each region, DNA was iso-
lated from BbΔ19-22 and BbΔ27-30 and subjected to
Southern blot analysis (Fig. 2b). A B. burgdorferi mutant
lacking bbf1-18 was also generated and verified as previ-
ously reported [8]. This mutant was included because
previous infection studies were only carried out for
28 days, and the intention of this study was to prolong
infection for 91 days to assess for long-term infection.
Lp28-1 mutant clones are capable of dissemination and
long-term infection in immunocompetent mice
To assess the individual infectivity profiles of the newly
generated mutants, groups of six C3H/HeN (C3H) mice
each were needle inoculated with either BbΔ1-18,
BbΔ19-22 or BbΔ27-30 clones. Two groups of three
C3H mice each were infected with wild type or lp28-1-
deficient (BbΔlp28-1) B. burgdorferi clones to serve as
positive and negative controls, respectively. As shown in
Table 3, blood samples collected at day 7 post infection
produced positive cultures for spirochetes in all inocu-
lated mouse groups except with the BbΔ19-22 mutant.
Positive blood cultures were obtained from only 3 out of
6 mice infected with the BbΔ19-22 clone. This pattern
was also observed for this same group of mice at day 14
after culture of ear biopsies, suggesting a possible delay
in dissemination to this tissue site. At day 14 post infec-
tion, cultures were positive for spirochetes in mice
infected with wild type, BbΔ1-18 and BbΔ27-30. As ex-
pected, spirochetes could not be detected from tissues
collected from day 14 onwards from mice infected with
the BbΔlp28-1 clone due to the lack of lp28-1 [8]. Long-
term infection (>21 days) was conducted to assess
whether the BbΔ1-18, BbΔ19-22 and BbΔ27-30 mutant
clones would eventually be cleared in infected mice. Ear
biopsies were collected at days 21 and 56 post infection,
and mice were sacrificed at day 91 to harvest heart,
bladder, ear, and joint tissues for spirochete culture. Ear
biopsies and cultured tissues from all mice were found
to be culture positive, demonstrating that the BbΔ1-18,
BbΔ19-22 and BbΔ27-30 clones were fully capable of
dissemination and long-term persistent infection
(Table 3).
Lp28-1 mutants are capable of downregulating ospC
expression during host infection
Associated with the development of the host-acquired
immune response is OspC downregulation and increased
synthesis of VlsE on lp28-1 [23, 24]. To determine if the
deletion of bbf1-18, bbf19-22 or bbf27-30 has an effect
on ospC expression during infection of a murine host,
groups of 3 C3H mice each were needle inoculated with
105 spirochetes of either BbΔ1-18, BbΔ19-22 or BbΔ27-
30. Two additional groups were infected with wild type
or BbΔlp28-1 clones to serve as controls. For each
group, mice were infected for a duration of either 21 or
91 days; these time points were chosen to assess ospC
expression levels during early and late stages of infec-
tion, respectively. On day 21 and 91 post infection, heart
and bladder tissue samples were collected for RNA ex-
traction. Ear biopsy tissue was also collected on days 13,
21, 56 and 91 for RNA extraction as a way to assess the
ospC transcription profile during infection without sacri-
ficing mice. Expression of ospC was normalized against
the flaB housekeeping gene and compared to mRNA of
late log phase in vitro-grown B. burgdorferi wild type.
Relative expression levels of ospC transcripts were de-
termined by digital droplet PCR (Fig. 3). FlaB and ospC
transcripts were detected at day 13 in tissues collected
from mice infected with BbΔlp28-1 clone, which corre-
lated with culture results (see Table 3). Data for this
clone was not collected after day 21 as all mice success-
fully cleared infection after this time point. Relative
levels of ospC expression between tissues infected with
the wild type and mutant clones were compared using a
Student’s t-test. Results presented in Fig. 3a show nor-
malized ospC expression from spirochetes in bladder tis-
sue relative to flaB transcripts. No significant difference
was observed between the wild type and mutant clones
recovered from bladder tissues at day 21. At day 91 post
infection, ospC expression by BbΔ1-18 spirochetes col-
lected from bladder tissues of mice was significantly
Table 3 Infectivity of B. burgdorferi clones in C3H mice
Days post infection:
7 14 21 56 91
B. burgdorferi clone Blood Ear Heart Bladder Ear Joint
Wild type 3/3* 3/3 3/3 3/3 3/3 3/3 3/3 3/3
BbΔ1-18 6/6 6/6 6/6 6/6 6/6 6/6 6/6 6/6
BbΔ19-22 3/6 3/6 6/6 6/6 6/6 6/6 6/6 6/6
BbΔ27-30 6/6 5/6 6/6 6/6 6/6 6/6 6/6 6/6
BbΔlp28-1 3/3 1/3 0/3 0/3 0/3 0/3 0/3 0/3
*Values listed correspond to numbers of positive cultures/number of mice
tested. Six or three mice were used for each B. burgdorferi clone
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Fig. 3 (See legend on next page.)
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repressed relative to that from wild type-infected blad-
ders (p = 0.007). No statistical difference was noted with
the other clones. Spirochetes recovered from heart tissue
at both day 21 and 91 showed no significant difference
in ospC expression (Fig. 3b).
For ear tissue, normalized ospC expression could be
determined from day 13 onwards (Fig. 3c). No significant
difference in ospC expression was observed between wild
type and the mutant clones recovered from infected ear
tissues collected at day 13, 21 and 91. At day 56 post
infection, the BbΔ19-22 clone was found to have a signifi-
cantly higher level of ospC expression compared to the
wild type (p = 0.043), while no difference was noted with
the other two mutant clones. Taken together, the results
from the mice infection studies and RT-qPCR analysis
suggest that the lp28-1 regions targeted for deletion are
not important for persistent infection by B. burgdorferi,
and have little to no lasting effects on the expression/re-
pression of ospC.
Discussion
Gene conversion at the vls locus on lp28-1 results in
antigenic variation of VlsE, which has been demon-
strated repeatedly to be essential for immune evasion
and persistence by the Lyme disease pathogen [2, 3, 8, 9,
25]. The question remained whether lack of the vls locus
alone explains the intermediate infectivity phenotype ex-
hibited by clones lacking the lp28-1 plasmid. Previous
studies have excluded all remaining genes as having an
effect on persistent infection, with the exception of the
genetic loci bbf19-22 and bbf27-30 [8, 9]. A B. burgdor-
feri mutant lacking bbf1-18 that was previously reported
[8] was included in the present study because previous
infection studies were only carried out for 28 days, and
the intention of this study was to prolong infection for
91 days to assess long-term persistence. The bbf1-18 re-
gion has several conserved coding regions, short genes,
and pseudogenes. In addition, a number of genes in this
region (bbf03, bbf05, bbf10, and bbf18) have been identi-
fied as potentially important for infectivity [12]. The
bbf19-22 region encodes one pseudogene (bbf19), a con-
served hypothetical protein (bbf20), a short gene (bbf21)
and a putative p23 protein (bbf23). Region bbf27-30 en-
codes mostly short genes (bbf27-29) and one pseudogene
(bbf30; [20]. Although the possibility has been raised
that one or more of these genes could be involved in in-
fectivity or persistence, the data reported here demon-
strate that lp28-1 mutant clones lacking bbf1-18, bbf19-
22 or bbf27-30 were fully capable of tissue dissemination
and long-term infection of an immunocompetent mur-
ine host. This strongly suggests that these non-vls genes
of lp28-1 do not play a role in persistent infection by the
Lyme disease pathogen.
A previous study suggested that failure of immune
evasion by clones lacking lp28-1 might also be due to al-
tered expression of the surface lipoprotein, OspC. It was
reported that ospC expression by lp28-1− spirochetes
was abnormally high, suggesting an impairment in
downregulation of this protein [14]. OspC is required
for the establishment of mammalian infection and is an
effective immune target that has to be downregulated to
avoid immune clearance [18, 26, 27]. Regulation of anti-
gen expression has been shown to be essential for spiro-
chete survival within the complex enzootic cycle
involving the tick and mammal [16, 23, 28–30]. OspC
production increases when the tick feeds [30, 31], and
has been shown to be required for B. burgdorferi to es-
tablish infection in the mammal [26, 27, 32–34]. How-
ever, OspC is dispensable during persistent infection [27,
35], and it has been reported that its continued expres-
sion in an immunocompetent animal is detrimental to B.
burgdorferi survival [18]. This suggests that B. burgdor-
feri must downregulate OspC following a specific
humoral response as a strategy to evade [28] host im-
munity and ensure persistence in the mammalian host.
Failure of OspC downregulation by spirochetes lacking
lp28-1 has been previously shown, and it has been sug-
gested that OspC regulation by genes on this plasmid
may be a potential mechanism of immune evasion [14].
Despite the observed ability of the mutant clones in
the present study to persistently infect mice, an add-
itional component of this study was to assess whether
genes within the bbf01-22 or bbf27-30 regions are poten-
tially responsible for the increased ospC expression
(See figure on previous page.)
Fig. 3 qRT-PCR analysis of ospC transcript levels in various tissue sites of infected mice. ospC expression profile of spirochetes recovered from the
bladder (a), heart (b), and ear tissue (c) of mice infected with wild type, BbΔ1-18, BbΔ19-22 or BbΔ27-30 is shown. ospC expression was normalized
against flaB and compared to mRNA of in vitro-grown B. burgdorferi wild-type cells grown to late log phase. Asterisks show mutant clones with
ospC expression levels that were statistically different from the wild type using statistical analyses described in Methods. a) In bladder tissue, no difference
in ospC expression was observed at day 21. At day 91, spirochetes from wild type-infected tissues had a statistically significant difference when compared
to BbΔ1-18 infected tissues (p= 0.007). b) Spirochetes in heart tissue samples showed no significant difference when compared to wild type-infected tissues
at both days 21 and 91. c) Spirochetes in the ear tissue showed a general decline in ospC expression from day 13, which was lowest at day 21 and started
to rise at day 56. There was no significant difference in ospC expression noted at day 13, 21 and 91. At day 56, spirochetes from mice infected with
BbΔ19-22 had a higher expression of ospC when compared to those infected by the wild type (p = 0.043). **flaB and ospC transcripts were detected at day
13 in tissues collected from mice infected with BbΔlp28-1 clone, which correlated with culture results (see Table 3). Data for this clone was not collected
after day 21 as all mice successfully cleared infection after this time point
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previously observed for spirochetes lacking lp28-1. FlaB
and ospC mRNA transcripts were consistently detected
from ear tissues at day 13 post infection. At day 12, it
has been shown that ospC is abundantly expressed in
the skin compared to the heart and joint [17], making
the skin a reliable tissue to observe ospC expression dur-
ing early infection without sacrificing the animal. Anti-
OspC antibody is detectable at day 10, and then peaks at
days 24–45 before starting to decline [15]. Consistent
with this timeline, the results showed relatively high
levels of ospC expression in the ear at day 13 post infec-
tion when humoral immunity against OspC is not fully
established (Fig. 3c). By day 21 post infection, ospC tran-
script levels from all tissue samples collected from mice
infected with mutant or wild type spirochetes were
greatly reduced suggesting that the mutations generated
within lp28-1 did not affect OspC down regulation. This
is indicative of either immune selection against spiro-
chetes that abundantly express this lipoprotein and/or
persistence of spirochetes that decrease its expression.
Moreover, a general increase in ospC expression by both
the wild type and mutant clones was observed in in-
fected ear and bladder tissues at days 56 and 91, which
coincides with the reported decline of anti-OspC anti-
body [15] (Fig. 3a and c).
Overall, relatively comparable ospC expression levels
were observed for the wild type and mutant clones. The
wild type clone generally showed higher levels of ospC
expression, with the exception of day 56 when BbΔ19-22
mutant spirochetes colonizing ear tissue exhibited sig-
nificantly higher expression levels. Initial delay in tissue
colonization was also observed with this mutant at days
7 and 14 post infection. In the end, the higher ospC ex-
pression levels did not correspond to clearance of spiro-
chete infection as demonstrated by the long-term mouse
infection studies.
From the data presented in this study, the lp28-1 re-
gions targeted for deletion are not important for persist-
ent infection by B. burgdorferi, and have little to no
lasting effects on the expression/repression of ospC.
However, it is conceivable that the regions under study
may have a detectable phenotype in mice when given a
lower inoculum dose. Moreover, it is possible that these
regions could play a role in other aspects of infectivity;
both possibilities will require further study.
Conclusions
The data reported herein indicate that regions bbf1-18,
bbf19-22 and bbf27-30 of lp28-1 are not involved in per-
sistent infection by B. burgdorferi, and do not critically
alter the overall expression levels of ospC during murine
infection leading to immune clearance. Moreover, along
with the previous data involving mutation of non-vls loci
on lp28-1, these findings suggest that the vls locus may
be the sole genetic element on this plasmid responsible
for immune evasion and persistence exhibited by the
Lyme disease pathogen.
Acknowledgments
The authors thank the Call laboratory in the Paul G. Allen School for Global
Animal Health at Washington State University for the use of the digital
droplet instrument, and are indebted to Lisa Orfe for providing excellent
technical assistance. We also thank Allison James, Abdul Lone, and Jessica
Wong for critical reading of the manuscript.
Funding
This work was funded by an intramural grant (17A-2540-9830) by the College
of Veterinary Medicine at Washington State University.
Availability of data and material
The datasets generated during and/or analyzed during the current study are
available from the corresponding author on reasonable request.
Authors’ contributions
PHM carried out all experiments, contributed to data organization, analysis
and interpretation of the results, and writing of the final manuscript. TB
contributed to the design of the study, interpretation of the results, and
assisted in the drafting of the manuscript. All authors have read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The experimental procedures involving Mus musculus strains of inbred mice
were carried out in accordance with the American Association for
Accreditation of Laboratory Animal Care (AAALAC) protocol and the
institutional guidelines set by the Office of Campus Veterinarian at
Washington State University (Animal Welfare Assurance A3485-01 and USDA
registration number 91-R-002). Washington State University AAALAC and
institutional guidelines are in compliance with the U.S. Public Health Service
Policy on Humane Care and Use of Laboratory Animals. Mus musculus inbred
mice were maintained at Washington State University (Pullman, WA, USA) in an
AAALAC-accredited animal facility. The Washington State University Institutional
Animal Care and Use Committee reviewed and approved the animal protocols
associated with the current studies.
Received: 7 May 2016 Accepted: 4 August 2016
References
1. Bhate C, Schwartz RA. Lyme disease: Part I. Advances and perspectives.
J Am Acad Dermatol. 2011;64(4):619–36.
2. Zhang JR, Hardham JM, Barbour AG, Norris SJ. Antigenic variation in Lyme
disease borreliae by promiscuous recombination of VMP-like sequence
cassettes. Cell. 1997;89(2):275–85.
3. Zhang JR, Norris SJ. Genetic variation of the Borrelia burgdorferi gene vlsE
involves cassette-specific, segmental gene conversion. Infect Immun.
1998;66(8):3698–704.
4. Labandeira-Rey M, Seshu J, Skare JT. The absence of linear plasmid 25 or
28–1 of Borrelia burgdorferi dramatically alters the kinetics of experimental
infection via distinct mechanisms. Infect Immun. 2003;71(8):4608–13.
5. Labandeira-Rey M, Skare JT. Decreased infectivity in Borrelia burgdorferi
strain B31 is associated with loss of linear plasmid 25 or 28–1. Infect Immun.
2001;69(1):446–55.
6. Purser JE, Norris SJ. Correlation between plasmid content and infectivity in
Borrelia burgdorferi. Proc Natl Acad Sci U S A. 2000;97(25):13865–70.
7. Purser JE, Lawrenz MB, Caimano MJ, Howell JK, Radolf JD, Norris SJ. A
plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia
burgdorferi in a mammalian host. Mol Microbiol. 2003;48(3):753–64.
Magunda and Bankhead BMC Microbiology  (2016) 16:180 Page 8 of 9
8. Bankhead T, Chaconas G. The role of VlsE antigenic variation in the Lyme
disease spirochete: persistence through a mechanism that differs from
other pathogens. Mol Microbiol. 2007;65(6):1547–58.
9. Rogovskyy AS, Bankhead T. Variable VlsE is critical for host reinfection by the
Lyme disease spirochete. PLoS One. 2013;8(4):e61226.
10. Imai D, Holden K, Velazquez EM, Feng S, Hodzic E, Barthold SW. Influence
of arthritis-related protein (BBF01) on infectivity of Borrelia burgdorferi B31.
BMC Microbiol. 2013;13(1):100.
11. Hove PR, Haldorson GJ, Magunda F, Bankhead T. Presence of arp specifically
contributes to joint tissue edema associated with early-onset lyme arthritis.
Infect Immun. 2014;82(1):43–51.
12. Lin T, Gao L, Zhang C, Odeh E, Jacobs MB, Coutte L, Chaconas G, Philipp
MT, Norris SJ. Analysis of an ordered, comprehensive STM mutant library in
infectious Borrelia burgdorferi: insights into the genes required for mouse
infectivity. PLoS One. 2012;7(10):e47532.
13. Stewart PE, Chaconas G, Rosa P. Conservation of plasmid maintenance
functions between linear and circular plasmids in Borrelia burgdorferi.
J Bacteriol. 2003;185(10):3202–9.
14. Embers ME, Alvarez X, Ooms T, Philipp MT. The failure of immune response
evasion by linear plasmid 28-1-deficient Borrelia burgdorferi is attributable to
persistent expression of an outer surface protein. Infect Immun.
2008;76(9):3984–91.
15. Liang FT, Jacobs MB, Bowers LC, Philipp MT. An immune evasion
mechanism for spirochetal persistence in Lyme borreliosis. J Exp Med.
2002;195(4):415–22.
16. Liang FT, Nelson FK, Fikrig E. Molecular adaptation of Borrelia burgdorferi in
the murine host. J Exp Med. 2002;196(2):275–80.
17. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E. Borrelia
burgdorferi changes its surface antigenic expression in response to host
immune responses. Infect Immun. 2004;72(10):5759–67.
18. Xu Q, Seemanapalli SV, McShan K, Liang FT. Constitutive expression of outer
surface protein C diminishes the ability of Borrelia burgdorferi to evade
specific humoral immunity. Infect Immun. 2006;74(9):5177–84.
19. Grimm D, Eggers CH, Caimano MJ, Tilly K, Stewart PE, Elias AF, Radolf JD,
Rosa PA. Experimental assessment of the roles of linear plasmids lp25 and
lp28-1 of Borrelia burgdorferi throughout the infectious cycle. Infect Immun.
2004;72(10):5938–46.
20. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O,
Ketchum KA, Dodson R, Hickey EK, et al. Genomic sequence of a Lyme
disease spirochaete, Borrelia burgdorferi. Nature. 1997;390(6660):580–6.
21. Elias AF, Stewart PE, Grimm D, Caimano MJ, Eggers CH, Tilly K, Bono JL,
Akins DR, Radolf JD, Schwan TG, et al. Clonal polymorphism of Borrelia
burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain
background. Infect Immun. 2002;70(4):2139–50.
22. Samuels DS. Electrotransformation of the spirochete Borrelia burgdorferi.
Methods Mol Biol. 1995;47:253–9.
23. Crother TR, Champion CI, Whitelegge JP, Aguilera R, Wu XY, Blanco DR,
Miller JN, Lovett MA. Temporal analysis of the antigenic composition of
Borrelia burgdorferi during infection in rabbit skin. Infect Immun.
2004;72(9):5063–72.
24. Hodzic E, Feng S, Freet KJ, Barthold SW. Borrelia burgdorferi population
dynamics and prototype gene expression during infection of
immunocompetent and immunodeficient mice. Infect Immun.
2003;71(9):5042–55.
25. Zhang JR, Norris SJ. Kinetics and in vivo induction of genetic variation of
vlsE in Borrelia burgdorferi. Infect Immun. 1998;66(8):3689–97.
26. Tilly K, Krum JG, Bestor A, Jewett MW, Grimm D, Bueschel D, Byram R,
Dorward D, Vanraden MJ, Stewart P, et al. Borrelia burgdorferi OspC protein
required exclusively in a crucial early stage of mammalian infection. Infect
Immun. 2006;74(6):3554–64.
27. Seemanapalli SV, Xu Q, McShan K, Liang FT. Outer surface protein C is a
dissemination-facilitating factor of Borrelia burgdorferi during mammalian
infection. PLoS One. 2010;5(12):e15830.
28. Radolf JD, Samuels DS. Borrelia : molecular biology, host interaction, and
pathogenesis. Norfolk, UK: Caister Academic Press; 2010.
29. Ohnishi J, Piesman J, de Silva AM. Antigenic and genetic heterogeneity of
Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci
U S A. 2001;98(2):670–5.
30. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer
surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad
Sci U S A. 1995;92(7):2909–13.
31. Schwan TG, Piesman J. Temporal changes in outer surface proteins A and C
of the lyme disease-associated spirochete, Borrelia burgdorferi, during the
chain of infection in ticks and mice. J Clin Microbiol. 2000;38(1):382–8.
32. Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, Bueschel DM, Schwan TG,
Policastro PF, Elias AF, Rosa PA. Outer-surface protein C of the Lyme disease
spirochete: a protein induced in ticks for infection of mammals. Proc Natl
Acad Sci U S A. 2004;101(9):3142–7.
33. Stewart PE, Wang X, Bueschel DM, Clifton DR, Grimm D, Tilly K, Carroll JA,
Weis JJ, Rosa PA. Delineating the requirement for the Borrelia burgdorferi
virulence factor OspC in the mammalian host. Infect Immun.
2006;74(6):3547–53.
34. Tilly K, Bestor A, Jewett MW, Rosa P. Rapid clearance of Lyme disease
spirochetes lacking OspC from skin. Infect Immun. 2007;75(3):1517–9.
35. Tilly K, Bestor A, Rosa PA. Lipoprotein succession in Borrelia burgdorferi:
similar but distinct roles for OspC and VlsE at different stages of mammalian
infection. Mol Microbiol. 2013;89(2):216–27.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Magunda and Bankhead BMC Microbiology  (2016) 16:180 Page 9 of 9
